O	0	6	Eleven
O	6	7	-
O	7	11	year
O	12	18	follow
O	18	19	-
O	19	21	up
O	22	24	of
O	25	26	a
O	27	37	randomized
O	38	43	study
O	44	46	of
B-intervention	47	55	pectoral
I-intervention	56	62	fascia
I-intervention	63	75	preservation
O	76	81	after
O	82	92	mastectomy
O	93	96	for
O	97	102	early
O	103	109	breast
O	110	116	cancer
O	116	117	.

O	118	121	The
O	122	129	present
O	130	135	study
O	136	143	reports
O	144	151	results
O	152	154	of
O	155	156	a
O	157	167	randomized
O	168	173	trial
O	174	176	in
O	177	182	which
O	183	189	breast
O	190	196	cancer
O	197	205	patients
O	206	214	operated
O	215	219	with
O	220	229	preserved
O	230	238	pectoral
O	239	245	fascia
O	246	254	compared
O	255	257	to
O	258	265	removal
O	266	268	of
O	269	272	the
O	273	281	pectoral
O	282	288	fascia
O	289	295	showed
O	296	297	a
O	298	303	trend
O	304	310	toward
O	311	313	an
O	314	323	increased
O	324	328	risk
O	329	332	for
O	333	338	chest
O	339	343	wall
O	344	354	recurrence
O	355	358	The
O	359	362	aim
O	363	365	of
O	366	369	the
O	370	375	study
O	376	379	was
O	380	382	to
O	383	389	assess
O	390	397	whether
O	398	401	the
O	402	411	different
O	412	422	procedural
O	423	428	modes
O	429	432	had
O	433	436	any
O	437	443	impact
O	444	446	on
O	447	455	survival
O	456	458	or
O	459	464	local
O	465	472	control
O	473	475	in
O	476	482	breast
O	483	489	cancer
O	490	498	patients
O	499	507	followed
O	508	510	in
O	511	514	the
O	515	519	long
O	520	524	term
O	524	525	.

O	526	529	The
O	530	535	trial
O	536	544	included
B-total-participants	545	548	247
B-eligibility	549	557	patients
I-eligibility	558	562	with
I-eligibility	563	569	breast
I-eligibility	570	576	cancer
I-eligibility	577	580	who
I-eligibility	581	590	underwent
I-eligibility	591	599	modified
I-eligibility	600	607	radical
I-eligibility	608	618	mastectomy
O	619	621	in
O	622	626	five
B-location	627	634	Swedish
O	635	644	hospitals
O	645	652	between
O	653	657	1993
O	658	661	and
O	662	666	1997
O	666	667	.

O	668	671	The
O	672	678	median
O	679	685	follow
O	685	686	-
O	686	688	up
O	689	693	time
O	694	697	was
O	698	700	11
O	701	706	years
O	706	707	.

O	708	711	The
O	712	720	patients
O	721	725	were
O	726	736	randomized
O	737	744	between
B-control	745	752	removal
O	753	754	(
O	754	755	n
O	756	757	=
B-control-participants	758	761	122
O	761	762	)
O	763	769	versus
O	770	782	preservation
O	783	784	(
O	784	785	n
O	786	787	=
B-intervention-participants	788	791	125
O	791	792	)
O	793	795	of
O	796	799	the
O	800	808	pectoral
O	809	815	fascia
O	815	816	.

O	817	820	The
B-outcome	821	827	breast
I-outcome	827	828	-
I-outcome	828	834	cancer
I-outcome	834	835	-
I-outcome	835	843	specific
I-outcome	844	852	survival
I-outcome	853	855	at
I-outcome	856	858	10
I-outcome	859	864	years
O	865	868	was
O	869	871	73
O	871	872	%
O	872	873	.

O	874	881	Removal
O	882	884	or
O	885	897	preservation
O	898	900	of
O	901	904	the
O	905	913	pectoral
O	914	920	fascia
O	921	924	had
O	925	927	no
O	928	939	significant
O	940	946	impact
O	947	949	on
B-outcome	950	955	chest
I-outcome	955	956	-
I-outcome	956	960	wall
I-outcome	961	971	recurrence
I-outcome	972	976	rate
I-outcome	977	979	or
I-outcome	980	986	breast
I-outcome	986	987	-
I-outcome	987	993	cancer
I-outcome	993	994	-
I-outcome	994	1002	specific
I-outcome	1003	1011	survival
O	1011	1012	.

O	1013	1014	A
O	1015	1020	total
O	1021	1023	of
B-iv-bin-abs	1024	1026	18
O	1027	1035	patients
O	1036	1040	with
B-outcome	1041	1046	chest
I-outcome	1046	1047	-
I-outcome	1047	1051	wall
I-outcome	1052	1062	recurrence
O	1063	1067	were
O	1068	1072	seen
O	1073	1075	in
O	1076	1079	the
O	1080	1085	group
O	1086	1095	allocated
O	1096	1098	to
O	1099	1107	pectoral
O	1108	1114	fascia
O	1115	1127	preservation
O	1128	1134	versus
O	1135	1136	a
O	1137	1142	total
O	1143	1145	of
B-cv-bin-abs	1146	1148	10
O	1149	1151	in
O	1152	1160	patients
O	1161	1170	allocated
O	1171	1173	to
O	1174	1182	pectoral
O	1183	1189	fascia
O	1190	1197	removal
O	1198	1199	(
O	1199	1205	hazard
O	1206	1211	ratio
O	1212	1213	=
O	1214	1215	1
O	1215	1216	.
O	1216	1217	8
O	1217	1218	,
O	1219	1221	95
O	1221	1222	%
O	1223	1233	confidence
O	1234	1242	interval
O	1243	1244	=
O	1245	1246	0
O	1246	1247	.
O	1247	1248	8
O	1248	1249	-
O	1249	1250	4
O	1250	1251	.
O	1251	1252	0
O	1252	1253	)
O	1253	1254	.

O	1255	1258	The
O	1259	1267	majority
O	1268	1270	of
O	1271	1274	the
O	1275	1280	chest
O	1280	1281	-
O	1281	1285	wall
O	1286	1297	recurrences
O	1298	1302	were
O	1303	1311	detected
O	1312	1313	0
O	1313	1314	-
O	1314	1315	5
O	1316	1321	years
O	1322	1337	postoperatively
O	1337	1338	.

O	1339	1342	The
B-outcome	1343	1353	cumulative
I-outcome	1354	1359	chest
I-outcome	1359	1360	-
I-outcome	1360	1364	wall
I-outcome	1365	1375	recurrence
I-outcome	1376	1381	rates
I-outcome	1382	1384	at
I-outcome	1385	1386	5
O	1387	1390	and
B-outcome	1391	1393	at
I-outcome	1394	1396	10
I-outcome	1397	1402	years
O	1403	1407	were
B-iv-bin-percent	1408	1410	13
O	1411	1414	and
B-iv-bin-percent	1415	1417	15
I-iv-bin-percent	1417	1418	%
O	1418	1419	,
O	1420	1432	respectively
O	1432	1433	,
O	1434	1436	in
O	1437	1445	patients
O	1446	1455	allocated
O	1456	1458	to
O	1459	1467	pectoral
O	1468	1474	fascia
O	1475	1487	preservation
O	1488	1491	and
B-cv-bin-percent	1492	1493	8
O	1494	1497	and
B-cv-bin-percent	1498	1499	9
I-cv-bin-percent	1499	1500	%
O	1501	1503	in
O	1504	1512	patients
O	1513	1522	allocated
O	1523	1525	to
O	1526	1534	pectoral
O	1535	1541	fascia
O	1542	1549	removal
O	1549	1550	.

O	1551	1555	With
O	1556	1560	long
O	1560	1561	-
O	1561	1565	term
O	1566	1572	follow
O	1572	1573	-
O	1573	1575	up
O	1576	1583	neither
O	1584	1587	the
B-outcome	1588	1593	chest
I-outcome	1594	1598	wall
I-outcome	1599	1609	recurrence
I-outcome	1610	1614	rate
O	1615	1618	nor
O	1619	1622	the
B-outcome	1623	1629	breast
I-outcome	1629	1630	-
I-outcome	1630	1636	cancer
I-outcome	1636	1637	-
I-outcome	1637	1645	specific
I-outcome	1646	1654	survival
O	1655	1658	was
O	1659	1672	significantly
O	1673	1683	influenced
O	1684	1686	by
O	1687	1690	the
O	1691	1703	preservation
O	1704	1706	of
O	1707	1710	the
O	1711	1719	pectoral
O	1720	1726	fascia
O	1726	1727	.

O	1728	1729	A
O	1730	1735	trend
O	1736	1742	toward
O	1743	1745	an
O	1746	1755	increased
O	1756	1760	risk
O	1761	1764	for
O	1765	1770	chest
O	1771	1775	wall
O	1776	1786	recurrence
O	1787	1790	was
O	1791	1799	observed
O	1800	1802	in
O	1803	1811	patients
O	1812	1816	with
O	1817	1826	preserved
O	1827	1835	pectoral
O	1836	1842	fascia
O	1842	1843	.

O	1844	1845	A
O	1846	1852	hazard
O	1853	1858	ratio
O	1859	1861	of
O	1862	1863	1
O	1863	1864	.
O	1864	1865	8
O	1866	1869	for
O	1870	1871	a
O	1872	1877	chest
O	1877	1878	-
O	1878	1882	wall
O	1883	1893	recurrence
O	1894	1896	in
O	1897	1905	patients
O	1906	1910	with
O	1911	1920	preserved
O	1921	1927	fascia
O	1928	1937	indicates
O	1938	1942	that
O	1943	1949	fascia
O	1949	1950	-
O	1950	1957	sparing
O	1958	1968	mastectomy
O	1969	1972	may
O	1973	1983	negatively
O	1984	1990	affect
O	1991	2000	prognosis
O	2000	2001	.
